1 Mouse Models of Thyroid Cancer: Bridging Pathogenesis and Novel Therapeutics.

2 Simultaneous presentation of parathyroid carcinoma, papillary thyroid cancer and ACTH-independent hypercortisolism due to benign cortical adenoma.

3 The Usefulness of the Thyroid Imaging Reporting and Data System in Determining Thyroid Malignancy.

4 Evaluation of the expression levels of BRAF mRNA in primary tumors of thyroid cancer using an ultrasensitive mutation assay.

5 Self-Catalyzed Rapid Synthesis of -Acylated/-Formylated α-Aminoketones and -Hydroxymethylated Formamides from 3-Aryl-2-Azirines and 2-Me/Ph-3-Aryl-2-Azirines.

6 Enrichment of geogenic ammonium in Quaternary alluvial-lacustrine aquifer systems: Evidence from carbon isotopes and DOM characteristics.

7 Twisting and bending photo-excited phenylethynylbenzenes - a theoretical analysis.

8 the evolution of biomarkers in thyroid cancer—from mass screening to a personalized biosignature

9 prognostic factors of a good response to initial therapy in children and adolescents with differentiated thyroid cancer

10 a rare silent killer: right atrial metastasis of thyroid hürthle cell carcinoma

11 metabolic reprogramming in thyroid carcinoma

12 thyroid cancer in ecuador, a 16 years population-based analysis (2001–2016)

13 epigenetic modifications in thyroid cancer cells restore nis and radio-iodine uptake and promote cell death

14 thyroid cancer in toxic and non-toxic multinodular goiter

15 Targeting mitochondria with Au-Ag@Polydopamine nanoparticles for papillary thyroid cancer therapy.

16 Novel design of NIR-triggered plasmonic nanodots capped mesoporous silica nanoparticles loaded with natural capsaicin to inhibition of metastasis of human papillary thyroid carcinoma B-CPAP cells in thyroid cancer chemo-photothermal therapy.

17 The Role of ATP-Binding Cassette Transporters in the Chemoresistance of Anaplastic Thyroid Cancer: A Systematic Review

18 Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

19 Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

20 Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer

21 Unusual Case of Malignant Struma Ovarii and Cervical Thyroid Cancer Preceded by Ovarian Teratoma: Case Report and Review of the Literature

22 Outcome of Cervical Lymph Nodes Dissection for Thyroid Cancer with Nodal Metastases: A Southeast Asian 3-Year Experience

23 Clinical, Pathological and Molecular Profiling of Radioactive Iodine Refractory Differentiated Thyroid Cancer.

24 Expression of ANGPTL2 and its impact on papillary thyroid cancer.

25 A practical method of I-131 thyroid cancer therapy dose optimization using estimated effective renal clearance

26 Amifostine does not protect thyroid cancer cells in DNA damaging in vitro models

27 Detection at Public Facilities of I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients.

28 Benchmarking health-related quality of life in thyroid cancer versus other cancers and United States normative data.

29 A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.

30 Papillary Thyroid Cancer in a Struma Ovarii in a 17-Year-Old Nulliparous Patient: A case Report.

31 Locally unresectable differentiated thyroid cancer: outcomes and perspectives.

32 p21-Activated Kinases in Thyroid Cancer

33 fibronectin 1 promotes migration and invasion of papillary thyroid cancer and predicts papillary thyroid cancer lymph node metastasis

34 adjuvant treatment with thyrotropin alpha for remnant ablation in thyroid cancer

35 simultaneous presentation of giant pheochromocytoma, primary hyperparathyroidism, and mixed-medullary-papillary thyroid cancer in men 2a

36 comparative clinicopathological and outcome analysis of differentiated thyroid cancer in saudi patients aged below 60 years and above 60 years

37 prognostic outcomes of tall cell variant papillary thyroid cancer: a meta-analysis

38 current state of diagnosis and treatment of medullary thyroid cancer

39 anaplastic transformation of papillary thyroid cancer in the retroperitoneum

40 update on epidemiology classification, and management of thyroid cancer

41 differences in mirna and mrna profile of papillary thyroid cancer variants

42 short-term side effects after radioiodine treatment in patients with differentiated thyroid cancer

43 radioactive iodine administration is associated with persistent related symptoms in patients with differentiated thyroid cancer

44 neoadjuvant therapy in differentiated thyroid cancer

45 review of factors related to the thyroid cancer epidemic

46 sistema glutation-s-transferase como fator prognóstico no carcinoma papilífero da tireoide gst genes expression as prognostic factor in papillary thyroid cancer

47 role of chemokines in thyroid cancer microenvironment: is cxcl8 the main player?

48 tsh variability of patients affected by differentiated thyroid cancer treated with levothyroxine liquid solution or tablet form

49 new treatment in advanced thyroid cancer

50 aggressive multimodal approach for anaplastic thyroid cancer and long-term survival

51 surgical treatment of advanced thyroid cancer invading the trachea, a case presentation and review of literature

52 the role of fluorine-18-fluorodeoxyglucose positron emission tomography in aggressive histological subtypes of thyroid cancer: an overview

53 resveratrol sensitizes selectively thyroid cancer cell to 131-iodine toxicity

54 patterns of cervical lymph node metastases in primary and recurrent papillary thyroid cancer

55 association of pre-mir-146a rs2910164 polymorphism with papillary thyroid cancer

56 a rare presentation of autonomously functioning papillary thyroid cancer: malignancy in marine-lenhart syndrome nodule

57 on the ret rearrangements in chernobyl-related thyroid cancer

58 Astatine-211: Endogenous Alpha-Radiotherapy for Thyroid Cancer

59 Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments

60 Navigating thyroid cancer: a theranostics odyssey &quot;joining the dots to make a line&quot;

Keyword Connections

Journals

Research Groups

Bibliographies